Table 1.
Baseline patients’ characteristics
| Group A (n = 100) | Group B (n = 100) | P | |
|---|---|---|---|
| Mean age (years) | 66.2 ± 7.7 | 67.4 ± 8 | 0.134 |
| Anticoagulant or antiplatelet therapy | 12 | 14 | 0.674 |
| Previous history of urinary tract infection | 0 | 3 | – |
| Diabetes mellitus | 14 | 13 | 0.836 |
| Positive DRE | 31 | 48 | 0.013 |
| Mean PSA (ng/mL) | 15.9 ± 28.1 | 13.3 ± 22.3 | 0.017 |
| Mean prostate volume (mL) | 65.5 ± 26.7 | 51 ± 24.6 | <0.001 |
| Mean MRI PIRADS score | 3.9 ± 0.9 | n.a. | – |
| Mean biopsy cores (n) | 17.8 ± 2.4 | 14.9 ± 0.8 | <0.001 |
PSA, prostate-specific antigen; DRE, digital rectal examination; MRI, magnetic resonance imaging; PIRADS, prostate imaging reporting and data system.